Check Cap Ltd
NASDAQ:CHEK
Check Cap Ltd
NASDAQ:CHEK
Price:
143
USD
0.7%
Market Closed
Market Cap:
$8.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Popular Picks
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Check Cap Ltd
Total Equity
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Check Cap Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Check Cap Ltd
NASDAQ:CHEK
|
Total Equity
-$1.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
B
|
Brainsway Ltd
TASE:BWAY
|
Total Equity
$70.1m
|
CAGR 3-Years
13%
|
CAGR 5-Years
29%
|
CAGR 10-Years
18%
|
|
|
Inmode Ltd
NASDAQ:INMD
|
Total Equity
$683.2m
|
CAGR 3-Years
7%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
Sisram Medical Ltd
HKEX:1696
|
Total Equity
$479.9m
|
CAGR 3-Years
4%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
A
|
Alpha Tau Medical Ltd
NASDAQ:DRTS
|
Total Equity
$77.1m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sofwave Medical Ltd
TASE:SOFW
|
Total Equity
$32.7m
|
CAGR 3-Years
0%
|
CAGR 5-Years
84%
|
CAGR 10-Years
N/A
|
|
No Stocks Found
Check Cap Ltd
Glance View
Check-Cap Ltd. is a clinical stage medical diagnostics company, which engages in the development of ingestible imaging capsule system for colorectal cancer screening. The company employs 81 full-time employees The company went IPO on 2015-02-19. The firm develops C-Scan, capsule-based, system ingestible imaging for colorectal cancer screening.
CHEK
Intrinsic Value
4.29
USD
Overvaluation 97%
See Also
What is Check Cap Ltd's Total Equity?
Total Equity
-1.5m
USD
-1.5m
USD
Based on the financial report for Dec 31, 2024, Check Cap Ltd's Total Equity amounts to -1.5m USD.
